| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |